PIC/S To Guide Member Inspectorates On Harmonizing GMP Deficiency Classifications
Executive Summary
Draft guidance soon will help the world’s leading pharmaceutical inspectorates align views on which drug GMP deficiencies are considered major – and which are truly critical.
You may also be interested in...
PIC/S Considers New System For Monitoring Compliance By Members
As more and more regulatory authorities line up to join the informal co-operative scheme for pharmaceutical inspectorates, PIC/S, there are plans to discuss the possible introduction of an annual reporting scheme to check ongoing compliance by existing members.
PIC/S Guideline Sets Harmonized Approach For Classifying GMP Deficiencies Worldwide
PIC/S has issued guidance to help member pharmaceutical inspectorates classify good manufacturing practice deficiencies to ensure there is a consistent view across inspectorates as to which deficiencies are “critical” or “major.”
Mexico and Argentina To Cut Burden for Pharma By Swapping GMP Reports
Medicines regulators in Mexico and Argentina have agreed to exchange good manufacturing practices inspection certificates.